These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3912729)

  • 1. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
    Maraninchi D
    Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 3. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of monoclonal antibodies in human bone marrow transplantation.
    Neudorf SM; Filipovich AH; Kersey JH
    Prog Clin Biol Res; 1984; 149():367-77. PubMed ID: 6377327
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
    Woolfrey AE; Neudorf S; Filipovich AH
    Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
    Gluckman E; Devergie A; Lokiec F; Traineau R; Cosset JM; Lemercier N; Varrin F; Cavazzana M; de Castro H; Meletis J
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):61-5. PubMed ID: 3321648
    [No Abstract]   [Full Text] [Related]  

  • 9. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
    Iriondo A; Richard C; Hermosa V; Conde E; Garijo J; Cuadrado MA; Bello C; Muruzábal MJ; Pérez-Encinas M; Zubizarreta A
    Med Clin (Barc); 1988 Oct; 91(13):488-92. PubMed ID: 3067007
    [No Abstract]   [Full Text] [Related]  

  • 11. [1st seminar of the Study Group on Bone Marrow Grafting on immunodepletion in the prevention of the graft-vs-host reaction. Marseilles, France, 4-6 October 1984. Abstracts].
    Nouv Rev Fr Hematol (1978); 1985; 27(6):351-75. PubMed ID: 3912730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
    Löwenberg B; Sizoo W; Wagemaker G; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Ned Tijdschr Geneeskd; 1986 May; 130(19):872-6. PubMed ID: 3520349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation by removal of T-cells].
    de Gast GC; Verdonck LF; van Kempen-Harteveld ML; Gerritsen H; Dekker AW
    Ned Tijdschr Geneeskd; 1986 May; 130(19):868-71. PubMed ID: 3520348
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms and avoidance of graft-versus-host disease.
    van Bekkum DW; Wagemaker G; Vriesendorp HM
    Transplant Proc; 1979 Mar; 11(1):189-95. PubMed ID: 377629
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunological aspects of bone marrow transplantation].
    Okulov VB; Afanas'ev BV
    Vopr Onkol; 1992; 38(4):387-96. PubMed ID: 1300731
    [No Abstract]   [Full Text] [Related]  

  • 16. Subsets of T lymphocyte subpopulations after human marrow transplantation defined by monoclonal antibodies and two-color fluorescence.
    Farrell C; Atkinson K; Chapman G; Penny R; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1704-6. PubMed ID: 3885509
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
    Noga SJ; Hess AD
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):28-33. PubMed ID: 8211214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects of T cell depletion of bone marrow for clinical marrow allografting.
    Cooley MA; Thornton M; Wong KL; Atkinson K; Biggs JC
    Transplant Proc; 1986 Apr; 18(2):334-6. PubMed ID: 3515670
    [No Abstract]   [Full Text] [Related]  

  • 19. Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
    Donnenberg AD; Hess AD; Duff SC; Bright EC; Noga SJ; Rowley SD; Saral R; Santos GW
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):144-52. PubMed ID: 3321641
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.